Cognition Therapeutics regains Nasdaq compliance on $1.00 bid price rule

* Cognition Therapeutics (NASDAQ:CGTX [https://seekingalpha.com/symbol/CGTX]) on Tuesday said that it has regained compliance with Nasdaq's minimum bid price requirement.
* The biotech firm received the compliance notification from the exchange on August 26, after it maintained a closing bid price of $1.00 or more for 10 consecutive days, that ended on August 25, 2025.
* CGTX +0.7% after hours to $2.88.
* Source: Press Release [https://seekingalpha.com/pr/20212315-cognition-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement]

MORE ON COGNITION THERAPEUTICS

* Cognition: Zervimesine AD Treatment Program FDA Alignment Means "Strong Buy" Rating [https://seekingalpha.com/article/4816775-cognition-zervimesine-ad-treatment-program-fda-alignment-means-strong-buy-rating]
* Cognition Therapeutics GAAP EPS of -$0.11 misses by $0.01 [https://seekingalpha.com/news/4482035-cognition-therapeutics-gaap-eps-of-0_11-misses-by-0_01]
* Cognition soars 35% after positive FDA meeting on Alzheimer's asset zervimesine [https://seekingalpha.com/news/4466583-cognition-soars-35-after-positive-fda-meeting-alzheimers-asset-zervimesine]
* Seeking Alpha’s Quant Rating on Cognition Therapeutics [https://seekingalpha.com/symbol/CGTX/ratings/quant-ratings]
* Historical earnings data for Cognition Therapeutics [https://seekingalpha.com/symbol/CGTX/earnings]